This work identifies PI3K signaling as an important target for precision medicine trials in meningioma patients.
No takes yet. Share an insight, caveat, or question.
Abedalthagafi et al. (2016) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: